Company Factsheet

Download this Company Fact Sheet as a PDF


Neuromonics, Inc., sells the clinically proven,Oasis and OasisPro to treat mild, moderate and severe tinnitus. With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus.

Neuromonics Tinnitus Treatment (NTT)

The NTT works with the Neuromonics Oasis, a non-invasive, compact, lightweight device that uses music – programmed for each patient’s individual audiological profile – to deliver a neural stimulus that targets the brain’s auditory pathways. The NTT targets the neurological processes of tinnitus: its audiological, attention-based and emotional aspects.

Oasis: Our purpose-built, easy to use device. Works with the clinically administered and monitored Neuromonics Tinnitus Treatment over a period of six-eight months, individually programmed music to target auditory pathways. For moderate to severe tinnitus disturbance.

OasisPro: The same Neuromonics Tinnitus Treatment delivered over an iOS-enabled device such as an iPhone, iPod, or iPad.


  • Non-invasive, compact, lightweight devices
  • Function like familiar consumer music players
  • Easy to use in daily activity
  • Reduction in tinnitus disturbance for more than 90 percent of patients in clinical trial setting


More than 200 licensed audiologists across four continents administer the Neuromonics Tinnitus Treatment. All are trained by Neuromonics.


P O BOX 351886

Westminster, CO 80035-1886


Media contacts:

Duane Knight

Neuromonics, Inc.


Aimee Bennett

Fagan Business Communications, Inc.